IQGAP3 and brain cancer: In contrast to IQGAP3, IQGAP2 expression was low in colorectal (42/53) and stomach cancer (23/47) whereas the expression was high in prostate (28/32) and brain cancer (19/49) in tumor tissue compared to uninvolved tissue (Fig 8).